J&J Files 8-K: Director Changes, Officer Comp, Shareholder Votes

Ticker: JNJ · Form: 8-K · Filed: 2025-04-30T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-compensation, director-changes

Related Tickers: JNJ

TL;DR

JNJ filed an 8-K detailing director changes, officer compensation, and shareholder votes.

AI Summary

Johnson & Johnson filed an 8-K on April 30, 2025, reporting on the departure of directors, election of new directors, and compensatory arrangements for officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits. Specific details regarding the compensatory arrangements or the matters voted upon are not elaborated in this summary.

Why It Matters

This filing provides transparency into Johnson & Johnson's corporate governance, including changes in leadership and executive compensation, which can impact investor confidence and company strategy.

Risk Assessment

Risk Level: low — The filing is routine and reports on corporate governance matters rather than significant financial events or operational changes.

Key Players & Entities

FAQ

What specific items were submitted to a vote of security holders?

The filing indicates that matters were submitted to a vote of security holders, but the specific proposals are not detailed in the provided text.

Who are the departing directors and the newly elected directors?

The filing states there was a departure of directors and an election of directors, but the names of these individuals are not specified in the provided text.

What are the details of the compensatory arrangements for certain officers?

The filing mentions compensatory arrangements for certain officers, but the specifics of these arrangements are not included in the provided text.

What financial statements and exhibits are included with this filing?

The filing notes that financial statements and exhibits are included, but their content is not described in the provided text.

What is the primary business of Johnson & Johnson?

Johnson & Johnson is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].

From the Filing

0000200406-25-000141.txt : 20250430 0000200406-25-000141.hdr.sgml : 20250430 20250430163048 ACCESSION NUMBER: 0000200406-25-000141 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250424 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250430 DATE AS OF CHANGE: 20250430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 25895958 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20250424.htm 8-K jnj-20250424 0000200406 false 0000200406 2025-04-24 2025-04-24 0000200406 us-gaap:CommonStockMember 2025-04-24 2025-04-24 0000200406 jnj:A1.150NotesDueNovember2028Member 2025-04-24 2025-04-24 0000200406 jnj:A2.700NotesDueFebruary2029Member 2025-04-24 2025-04-24 0000200406 jnj:A3.20NotesDueNovember2032Member 2025-04-24 2025-04-24 0000200406 jnj:A3.050NotesDueFebruary2033Member 2025-04-24 2025-04-24 0000200406 jnj:A1.650NotesDue2035Member 2025-04-24 2025-04-24 0000200406 jnj:A3.350NotesDueNovember2036Member 2025-04-24 2025-04-24 0000200406 jnj:A3.350NotesDueFebruary2037Member 2025-04-24 2025-04-24 0000200406 jnj:A3.550NotesDueNovember2044Member 2025-04-24 2025-04-24 0000200406 jnj:A3.600NotesDueFebruary2045Member 2025-04-24 2025-04-24 0000200406 jnj:A3.700NotesDueFebruary2055Member 2025-04-24 2025-04-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  April 24, 2025 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Ex

View on Read The Filing